Financial Performance - The company's operating revenue for Q3 2024 reached ¥1,082,970,366.62, representing a year-on-year increase of 19.92%[2] - Net profit attributable to shareholders for Q3 2024 was ¥146,351,133.85, a significant increase of 131.73% compared to the same period last year[2] - The basic and diluted earnings per share for Q3 2024 were both ¥0.55, reflecting a year-on-year increase of 129.17%[4] - Total operating revenue for the first three quarters of 2024 was CNY 3,125,390,090.31, a decrease of 2.61% compared to CNY 3,209,194,823.07 in the same period of 2023[20] - Net profit for the first three quarters of 2024 was CNY 317,474,354.86, an increase of 2.38% compared to CNY 308,745,291.11 in the same period of 2023[21] - Earnings per share for the first three quarters of 2024 were CNY 1.15, compared to CNY 1.13 in the same period of 2023[22] - Comprehensive income for the first three quarters of 2024 was CNY 367,041,293.44, compared to CNY 323,240,452.44 in the same period of 2023[22] Assets and Liabilities - Total assets at the end of Q3 2024 amounted to ¥7,873,442,974.15, an increase of 8.35% from the end of the previous year[4] - Total liabilities as of the end of the third quarter of 2024 amounted to CNY 2,036,039,313.17, an increase of 22.49% from CNY 1,662,319,359.19 at the end of the previous year[20] - Total equity attributable to shareholders of the parent company was CNY 5,582,058,548.97, an increase of 4.05% from CNY 5,365,596,147.58 in the previous year[20] - The company's total assets reached CNY 7,873,442,974.15, an increase from CNY 7,266,719,674.70 at the end of the previous year[20] Cash Flow - The net cash flow from operating activities for the year-to-date period decreased by 39.31% to ¥159,518,116.70 compared to the same period last year[4] - In the first three quarters of 2024, the net cash flow from operating activities was ¥159,518,116.70, a decrease of 39.4% compared to ¥262,852,224.14 in the same period of 2023[25] - Total cash inflow from operating activities was ¥3,382,595,024.60, down from ¥3,823,930,847.44, representing a decline of 11.5% year-over-year[25] - Cash outflow from operating activities totaled ¥3,223,076,907.90, compared to ¥3,561,078,623.30 in the previous year, indicating a decrease of 9.5%[25] - The cash flow from investment activities showed a net outflow of ¥639,071,697.05, an improvement from a net outflow of ¥1,055,233,440.43 in the same period last year[25] - Cash inflow from investment activities was ¥510,640,483.98, significantly higher than ¥102,670,916.39 in the previous year[25] - Cash inflow from financing activities was ¥1,419,260,000.00, up from ¥585,065,805.00, marking an increase of 142.6% year-over-year[25] - The net cash flow from financing activities was ¥234,402,342.05, a turnaround from a net outflow of ¥74,313,386.63 in the same period of 2023[25] - The ending balance of cash and cash equivalents was ¥799,490,399.41, down from ¥1,205,615,108.09 in the previous year[25] - The company reported a cash inflow of ¥450,000,000.00 from the recovery of investments, compared to ¥100,000,000.00 in the same period last year[25] Shareholder Information - The total number of common shareholders at the end of the reporting period is 23,529 shares[10] - Zhejiang Zhendai Holdings Co., Ltd. holds 132,739,480 shares, accounting for 49.82% of the total shares[10] Other Financial Metrics - The weighted average return on equity for Q3 2024 was 2.66%, an increase of 1.54 percentage points compared to the previous year[4] - The company reported a decrease of 20.59% in net profit attributable to shareholders after deducting non-recurring gains and losses for the year-to-date period[8] - Research and development expenses for the first three quarters of 2024 were CNY 98,872,971.89, a decrease from CNY 110,447,381.62 in the same period of 2023[20] - The company reported a significant increase in other comprehensive income after tax, totaling CNY 49,566,938.58 compared to CNY 14,495,161.33 in the previous year[21] - The company has not adopted new accounting standards or interpretations affecting the financial statements for the year[26] Business Operations - The overseas main business revenue for Q3 2024 was ¥645 million, an increase of 24.36% year-on-year, indicating a recovery in international operations[7] - The revenue from domestic hospital lines reached ¥278 million, showing a growth of 20.99% compared to the same period last year[7] - The company recognized a gain from the disposal of assets due to the acquisition of land use rights and properties, contributing positively to net profit[7] - The company signed an asset acquisition agreement for state-owned land use rights and buildings, with a total compensation amount of RMB 297.81 million, which is expected to increase net profit by approximately RMB 9.3 million[15] Current Assets and Liabilities - Current assets total RMB 3,113.70 million, up from RMB 2,719.81 million at the end of 2023, reflecting a growth of approximately 14.5%[16] - The company's cash and cash equivalents decreased to RMB 806.65 million from RMB 1,051.79 million, a decline of about 23.3%[16] - Accounts receivable increased to RMB 702.18 million from RMB 539.65 million, representing a growth of approximately 30.2%[16] - Inventory increased to RMB 820.81 million from RMB 800.81 million, showing a slight increase of about 2.5%[16] - The company reported a short-term loan of RMB 451.83 million, up from RMB 220.14 million, indicating an increase of approximately 105.5%[18] - The total non-current assets amount to RMB 4,759.74 million, an increase from RMB 4,546.91 million, reflecting a growth of approximately 4.7%[18]
振德医疗(603301) - 2024 Q3 - 季度财报